NorPept
View All Peptides
fatLoss

Semamax

Semaglutide

Semaglutide is a long-acting GLP-1 receptor agonist originally developed for the treatment of type 2 diabetes. It mimics the action of human GLP-1 to regulate blood sugar, insulin secretion, and appetite. Semaglutide has gained widespread use for weight management.

Molecular Data

99.3%

Purity

4113.58 g/mol

Molecular Weight

SEM-2026-0267

Batch Number

HPLC + Mass Spectrometry

Testing Method

Verified Pure

Lab Tested

Amino Acid Sequence

Modified GLP-1(7-37) analog with C-18 fatty acid chain

Research Studies

Insulin secretion and blood glucose regulation
Appetite and food intake reduction
Weight management in obese and overweight patients
Cardiometabolic marker improvement
Cardiovascular risk reduction in diabetics

Lab Verification

Scan to verify

Batch Number: SEM-2026-0267

Purity: 99.3%

Effect Profile

Recovery
1
Energy
2
Anti-Aging
2
Muscle
1
Fat Loss
5
Skin
1
Sleep
1
Cognitive
1
Expert Rating
4.5

Key Benefits

Enhances insulin secretion and lowers blood glucose
Significantly reduces appetite and food intake
Proven weight loss effects in obese and overweight patients
Improves cardiometabolic markers (HbA1c, LDL, blood pressure)
Reduces risk of major cardiovascular events in diabetics
Once-weekly dosing with sustained effect

Pairs Well With

These peptides are commonly stacked with Semamax for enhanced results.

Ready to explore Semamax?

Take our guided quiz to find peptides matched to your research objectives, or browse our full catalog.